615 related articles for article (PubMed ID: 24763920)
41. Mantle cell lymphoma in the orbital and adnexal region.
Rasmussen P; Sjö LD; Prause JU; Ralfkiaer E; Heegaard S
Br J Ophthalmol; 2009 Aug; 93(8):1047-51. PubMed ID: 19429588
[TBL] [Abstract][Full Text] [Related]
42. Primary, unilateral ocular adnexal lymphoma: disease progression and long-term survival.
Rootman DB; Mavrikakis I; Connors JM; Rootman J
Ophthalmic Plast Reconstr Surg; 2011; 27(6):405-9. PubMed ID: 21659919
[TBL] [Abstract][Full Text] [Related]
43. Natural killer/T-cell lymphoma with ocular and adnexal involvement.
Woog JJ; Kim YD; Yeatts RP; Kim S; Esmaeli B; Kikkawa D; Lee HB; Korn BS; Punja K; Habermann TM; Colgan JP; Salomao D; Cameron JD
Ophthalmology; 2006 Jan; 113(1):140-7. PubMed ID: 16360212
[TBL] [Abstract][Full Text] [Related]
44. Rates of Positive Findings on Positron Emission Tomography and Bone Marrow Biopsy in Patients With Ocular Adnexal Lymphoma.
Thuro BA; Ning J; Peng SA; Pace ST; Dudeja G; Ozgur O; Turturro F; Samaniego F; Hagemeister FB; Fayad LE; Fowler NH; Pinnix CC; Debnam JM; Esmaeli B
Ophthalmic Plast Reconstr Surg; 2017; 33(5):355-360. PubMed ID: 27636243
[TBL] [Abstract][Full Text] [Related]
45. Ocular adnexal lymphoma: A single-institution retrospective study.
Fernández CA; Henry RK; Shields CL; Bilyk JR; Lally SE; Eagle RC; Milman T
Saudi J Ophthalmol; 2021; 35(3):230-238. PubMed ID: 35601857
[TBL] [Abstract][Full Text] [Related]
46. [Lymphoma of the ocular adnexa].
Kakkassery V; Stübiger N; Adamietz IA; Tischoff I; Baraniskin A; Wunderlich IM
Ophthalmologe; 2015 Mar; 112(3):210-6. PubMed ID: 25693875
[TBL] [Abstract][Full Text] [Related]
47. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
48. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
Shields CL; Shields JA; Honavar SG; Demirci H
Ophthalmology; 2001 Dec; 108(12):2284-92. PubMed ID: 11733272
[TBL] [Abstract][Full Text] [Related]
49. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
50. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
[TBL] [Abstract][Full Text] [Related]
51. Primary follicular lymphoma of the gastrointestinal tract.
Misdraji J; Harris NL; Hasserjian RP; Lauwers GY; Ferry JA
Am J Surg Pathol; 2011 Sep; 35(9):1255-63. PubMed ID: 21836483
[TBL] [Abstract][Full Text] [Related]
52. Orbital Lymphoma-An International Multicenter Retrospective Study.
Olsen TG; Holm F; Mikkelsen LH; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Sjö LD; Vemuganti GK; Thuro BA; Heegaard S
Am J Ophthalmol; 2019 Mar; 199():44-57. PubMed ID: 30419193
[TBL] [Abstract][Full Text] [Related]
53. Rare presentations for lymphoid tumour of orbit, lids, lacrimal gland and conjunctiva.
Mortada A
Bull Ophthalmol Soc Egypt; 1974; 67():251-7. PubMed ID: 4466534
[No Abstract] [Full Text] [Related]
54. Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.
Paik JS; Cho WK; Lee SE; Choi BO; Jung SE; Park GS; Kim SH; Yang SW; Cho SG
Ann Hematol; 2012 Sep; 91(9):1393-401. PubMed ID: 22543827
[TBL] [Abstract][Full Text] [Related]
55. Monoclonal antibodies in the diagnosis of lymphoproliferative diseases of the orbit and orbital adnexae.
Norton AJ
Eye (Lond); 2006 Oct; 20(10):1186-8. PubMed ID: 17019417
[TBL] [Abstract][Full Text] [Related]
56. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.
Ferreri AJ; Ponzoni M; Guidoboni M; Resti AG; Politi LS; Cortelazzo S; Demeter J; Zallio F; Palmas A; Muti G; Dognini GP; Pasini E; Lettini AA; Sacchetti F; De Conciliis C; Doglioni C; Dolcetti R
J Natl Cancer Inst; 2006 Oct; 98(19):1375-82. PubMed ID: 17018784
[TBL] [Abstract][Full Text] [Related]
57. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy.
Hashimoto N; Sasaki R; Nishimura H; Yoshida K; Miyawaki D; Nakayama M; Uehara K; Okamoto Y; Ejima Y; Azumi A; Matsui T; Sugimura K
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1509-14. PubMed ID: 21664061
[TBL] [Abstract][Full Text] [Related]
58. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
[TBL] [Abstract][Full Text] [Related]
59. Feasibility of the TNM-based staging system of ocular adnexal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Lee SE; Paik JS; Cho WK; Choi BO; Lee SN; Jung SE; Park KS; Kang CS; Kim SH; Yang SW; Cho SG
Am J Hematol; 2011 Mar; 86(3):262-6. PubMed ID: 21328439
[TBL] [Abstract][Full Text] [Related]
60. Targeted monoclonal antibody therapy and radioimmunotherapy for lymphoproliferative disorders of the ocular adnexa.
Shome D; Esmaeli B
Curr Opin Ophthalmol; 2008 Sep; 19(5):414-21. PubMed ID: 18772675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]